Genetic relationships between high blood eosinophil count, asthma susceptibility, and asthma severity

References

• GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204–1222. doi:10.1016/S0140-6736(20)30925-9.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18(5):716–725. doi:10.1038/nm.2678.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (GINA). [accessed June 1, 2023. updated 2023]. Available at https://ginasthma.org.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43(2):343–373. [Published erratum appears in Eur Respir J 2022;59:1362020.] doi:10.1183/09031936.00202013.
   PubMed Web of Science ®Google Scholar
• Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med 2019;200(9):1102–1112. doi:10.1164/rccm.201901-0016OC.
   PubMed Web of Science ®Google Scholar
• Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC.
   PubMed Web of Science ®Google Scholar
• Trevor J, Lugogo N, Carr W, Moore WC, Soong W, Panettieri RA, Desai P, Trudo F, Ambrose CS.Jr Exacerbations in US severe asthma: incidence, characteristics, predictors, and effects of biologic treatments. Ann Allergy Asthma Immunol 2021;127(5):579–587.e1. doi:10.1016/j.anai.2021.07.010.
   PubMed Web of Science ®Google Scholar
• Bourdin A, Bjermer L, Brightling C, Brusselle GG, Chanez P, Chung KF, et al. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Eur Respir J 2019;54:1900900. doi:10.1183/13993003.00900-2019.
   PubMed Web of Science ®Google Scholar
• O’Byrne P, Fabbri LM, Pavord ID, Papi A, Petruzzelli S, Lange P. Asthma progression and mortality: the role of inhaled corticosteroids. Eur Respir J 2019;54:1900491. doi:10.1183/13993003.00491-2019.
   PubMed Web of Science ®Google Scholar
• D’Amato G, Vitale C, Molino A, Stanziola A, Sanduzzi A, Vatrella A, Mormile M, Lanza M, Calabrese G, Antonicelli L, et al. Asthma-related deaths. Multidiscip Respir Med 2016;11:37. doi:10.1186/s40248-016-0073-0.
   PubMed Web of Science ®Google Scholar
• Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, McMahon A, Morales J, Mountjoy E, Sollis E, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 2019;47(D1):D1005–D1012. doi:10.1093/nar/gky1120.
   PubMed Web of Science ®Google Scholar
• Li X, Ampleford EJ, Howard TD, Moore WC, Torgerson DG, Li H, Busse WW, Castro M, Erzurum SC, Israel E, et al. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol 2012;130(4):861–868.e7. doi:10.1016/j.jaci.2012.04.041.
   PubMed Web of Science ®Google Scholar
• Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thorleifsson G, Helgadottir H, Steinthorsdottir V, Stefansson H, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009;41(3):342–347. doi:10.1038/ng.323.
   PubMed Web of Science ®Google Scholar
• Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, Mead D, Bouman H, Riveros-Mckay F, Kostadima MA, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 2016;167(5):1415–1429.e19. doi:10.1016/j.cell.2016.10.042.
   PubMed Web of Science ®Google Scholar
• Guyatt A, John C, Williams AT, Shrine N, Reeve NF, Sayers I, Hall I, Wain LV, Sheehan N, Dudbridge F, SpiroMeta consortium, et al. Mendelian randomisation of eosinophils and other cell types in relation to lung function and disease. Thorax 2023;78(5):496–503. doi:10.1136/thoraxjnl-2021-217993.
   PubMed Web of Science ®Google Scholar
• Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015;12(3):e1001779. doi:10.1371/journal.pmed.1001779.
   PubMed Web of Science ®Google Scholar
• Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O’Connell J, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 2018;562(7726):203–209. doi:10.1038/s41586-018-0579-z.
   PubMed Web of Science ®Google Scholar
• Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, All of Us Research Program Investigators, et al. The "All of Us" research program. N Engl J Med 2019;381:668–676.
   PubMedGoogle Scholar
• Ramirez AH, Gebo KA, Harris PA. Progress with the all of us research program: opening access for researchers. JAMA 2021;325(24):2441–2442. doi:10.1001/jama.2021.7702.
   PubMed Web of Science ®Google Scholar
• Ramirez AH, Sulieman L, Schlueter DJ, Halvorson A, Qian J, Ratsimbazafy F, Loperena R, Mayo K, Basford M, Deflaux N, et al. The All of Us Research Program: data quality, utility, and diversity. Patterns (N Y) 2022;3(8):100570. doi:10.1016/j.patter.2022.100570.
   PubMedGoogle Scholar
• Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163(7):670–675. doi:10.1093/aje/kwj063.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81(3):559–575. doi:10.1086/519795.
   PubMed Web of Science ®Google Scholar
• Li X, Christenson SA, Modena B, Li H, Busse WW, Castro M, Denlinger LC, Erzurum SC, Fahy JV, Gaston B, et al. Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways. J Allergy Clin Immunol 2021;147(3):894–909. doi:10.1016/j.jaci.2020.07.030.
   PubMed Web of Science ®Google Scholar
• Yin L, Zhang H, Tang Z, Xu J, Yin D, Zhang Z, Yuan X, Zhu M, Zhao S, Li X, et al. rMVP: a Memory-efficient, visualization-enhanced, and parallel-accelerated tool for genome-wide association study. Genomics Proteomics Bioinformatics 2021;19(4):619–628. doi:10.1016/j.gpb.2020.10.007.
   PubMed Web of Science ®Google Scholar
• Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 2017;46(6):1734–1739. doi:10.1093/ije/dyx034.
   PubMed Web of Science ®Google Scholar
• Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology 2017;28(1):30–42. doi:10.1097/EDE.0000000000000559.
   PubMed Web of Science ®Google Scholar
• Demenais F, Margaritte-Jeannin P, Barnes KC, Cookson WOC, Altmüller J, Ang W, Barr RG, Beaty TH, Becker AB, Beilby J, et al. Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet 2018;50(1):42–53. doi:10.1038/s41588-017-0014-7.
   PubMed Web of Science ®Google Scholar
• Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med 2018;197(1):22–37. doi:10.1164/rccm.201611-2232PP.
   PubMed Web of Science ®Google Scholar
• Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH, et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J 2020;55:1901874. doi:10.1183/13993003.01874-2019.
   PubMed Web of Science ®Google Scholar
• Li X, Hastie AT, Peters MC, Hawkins GA, Phipatanakul W, Li H, Moore WC, Busse WW, Castro M, Erzurum SC, et al. Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma. J Allergy Clin Immunol 2020;145(1):430–433. doi:10.1016/j.jaci.2019.08.031.
   PubMed Web of Science ®Google Scholar
• Li H, Castro M, Denlinger LC, Erzurum SC, Fahy JV, Gaston B, Israel E, Jarjour NN, Levy BD, Mauger DT, et al. Investigations of a combination of atopic status and age of asthma onset identify asthma subphenotypes. J Asthma 2023;60(10):1843–1852. doi:10.1080/02770903.2023.2193634.
   PubMed Web of Science ®Google Scholar
• Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O’Brien C, Korn S, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 2015;3(5):355–366. doi:10.1016/S2213-2600(15)00042-9.
   PubMed Web of Science ®Google Scholar
• Chupp GL, Bradford ES, Albers FC, Bratton DJ, Wang-Jairaj J, Nelsen LM, Trevor JL, Magnan A, Ten Brinke A. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial. Lancet Respir Med 2017;5(5):390–400. doi:10.1016/S2213-2600(17)30125-X.
   PubMed Web of Science ®Google Scholar
• Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkström V, et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet 2016;388(10056):2115–2127. doi:10.1016/S0140-6736(16)31324-1.
   PubMed Web of Science ®Google Scholar
• FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, et al. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2016;388(10056):2128–2141. doi:10.1016/S0140-6736(16)31322-8.
   PubMed Web of Science ®Google Scholar
• Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 2018;378(26):2486–2496. doi:10.1056/NEJMoa1804092.
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med 2022;386(2):157–171. doi:10.1056/NEJMra2032506.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Severe adult asthmas: integrating clinical features, biology, and therapeutics to improve outcomes. Am J Respir Crit Care Med 2021;203(7):809–821. doi:10.1164/rccm.202009-3631CI.
   PubMed Web of Science ®Google Scholar
• Drazen JM, Harrington D. New biologics for asthma. N Engl J Med 2018;378(26):2533–2534. doi:10.1056/NEJMe1806037.
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Wechsler ME, FitzGerald JM, Menzies-Gow A, Wu Y, Hirsch I, et al. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma. Eur Respir J 2018;52:1800936. doi:10.1183/13993003.00936-2018.
   PubMed Web of Science ®Google Scholar
• Brusselle G, Germinaro M, Weiss S, Zangrilli J. Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils. Pulm Pharmacol Ther 2017;43:39–45. doi:10.1016/j.pupt.2017.01.011.
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, Brightling CE, Griffiths JM, Hellqvist Å, Bowen K, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med 2021;384(19):1800–1809. doi:10.1056/NEJMoa2034975.
   PubMed Web of Science ®Google Scholar
• Mallah N, Rodriguez-Segade S, Gonzalez-Barcala FJ, Takkouche B. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis. Pediatr Allergy Immunol 2021;32(3):465–478. doi:10.1111/pai.13403.
   PubMed Web of Science ®Google Scholar
• Vuckovic D, Bao EL, Akbari P, Lareau CA, Mousas A, Jiang T, Chen M-H, Raffield LM, Tardaguila M, Huffman JE, et al. The polygenic and monogenic basis of blood traits and diseases. Cell 2020;182(5):1214–1231.e11. doi:10.1016/j.cell.2020.08.008.
   PubMed Web of Science ®Google Scholar
• El-Husseini ZW, Vonk JM, van den Berge M, Gosens R, Koppelman GH. Association of asthma genetic variants with asthma-associated traits reveals molecular pathways of eosinophilic asthma. Clin Transl Allergy 2023;13:e12239.
   PubMed Web of Science ®Google Scholar
• Niessen NM, Fricker M, McDonald VM, Gibson PG. T2-low: what do we know?: Past, present, and future of biologic therapies in noneosinophilic asthma. Ann Allergy Asthma Immunol 2022;129(2):150–159. doi:10.1016/j.anai.2022.04.020.
   PubMed Web of Science ®Google Scholar
• Ricciardolo FLM, Sprio AE, Baroso A, Gallo F, Riccardi E, Bertolini F, et al. Characterization of T2-low and T2-high asthma phenotypes in real-life. Biomedicines 2021;9:1684. doi:10.3390/biomedicines9111684.
   PubMed Web of Science ®Google Scholar
• GTEx Consortium Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015;348(6235):648–660. doi:10.1126/science.1262110.
   PubMed Web of Science ®Google Scholar
• Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T, Rosen N, Kohn A, Twik M, Safran M, et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford) 2017;2017 doi:10.1093/database/bax028.
   PubMedGoogle Scholar
• Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res 2002;12(6):996–1006. doi:10.1101/gr.229102.
   PubMed Web of Science ®Google Scholar
• Pividori M, Schoettler N, Nicolae DL, Ober C, Im HK. Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies. Lancet Respir Med 2019;7(6):509–522. doi:10.1016/S2213-2600(19)30055-4.
   PubMed Web of Science ®Google Scholar
• Shrine N, Portelli MA, John C, Soler Artigas M, Bennett N, Hall R, Lewis J, Henry AP, Billington CK, Ahmad A, et al. Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study. Lancet Respir Med 2019;7(1):20–34. doi:10.1016/S2213-2600(18)30389-8.
   PubMed Web of Science ®Google Scholar
• Li X, Li H, Christenson SA, Castro M, Denlinger LC, Erzurum SC, Fahy JV, Gaston BM, Israel E, Jarjour NN, et al. Genetic analyses of chr11p15.5 region identify MUC5AC-MUC5B associated with asthma-related phenotypes. J Asthma 2023;60(10):1824–1835. doi:10.1080/02770903.2023.2193631.
   PubMed Web of Science ®Google Scholar
• Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014;23(R1):R89–R98. doi:10.1093/hmg/ddu328.
   PubMed Web of Science ®Google Scholar
• Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 2018;362:k601. doi:10.1136/bmj.k601.
   PubMed Web of Science ®Google Scholar
• Li X, Hawkins GA, Ampleford EJ, Moore WC, Li H, Hastie AT, Howard TD, Boushey HA, Busse WW, Calhoun WJ, et al. Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. J Allergy Clin Immunol 2013;132(2):313–320.e15. doi:10.1016/j.jaci.2013.01.051.
   PubMed Web of Science ®Google Scholar